Transcranial Low Intensity Focused Ultrasound Neuromodulation as a Probe to Study Human Emotion and Cognitive Function
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Andrea Boscutti, MD
- Phone Number: 713-486-2622
- Email: Andrea.Boscutti@uth.tmc.edu
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- The University of Texas Health Science Center at Houston
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Must be right-handed
- Must be illicit drug-free at the time of scanning as appropriate (verified by negative urine drug screen)
- Must be healthy (without medical, neurological, psychiatric illness)
- Must be psychotropic medication free (≥ 14 days)
Exclusion Criteria:
- Must not be a smoker
- Females must not be pregnant or nursing
- Must not suffer from claustrophobia
- Must not meet exclusion criteria for MRI scanning (i.e., non-fixed magnetizable objects)
- Must not have ongoing, chronic, or relapsing/remitting medical, psychiatric,or neurological illness as determined by a combination of history, medical record, and/or examination.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: LIFUP sonication to the amygdala
|
LIFUP sonication to amygdala will be performed.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in amygdala activity indicated by functional magnetic resonance imaging (fMRI) scan blood oxygen-level-dependent (BOLD) signal
Time Frame: baseline, 5 mins post-LIFUP sonication
|
baseline, 5 mins post-LIFUP sonication
|
|
Changes in brain resting state functional network as indicated by fMRI scan connectivity measures
Time Frame: baseline, 10-20 mins post-LIFUP sonication
|
baseline, 10-20 mins post-LIFUP sonication
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in performance on Reward Task
Time Frame: baseline, 1-hour post-LIFUP sonication
|
baseline, 1-hour post-LIFUP sonication
|
|
Tolerability of LIFUP sonication as assessed number of adverse events
Time Frame: baseline, immediately after LIFUP sonication
|
baseline, immediately after LIFUP sonication
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Jair Soares, MD, PhD, The University of Texas Health Science Center, Houston
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HSC-MS-21-0570
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.